ADVISORY...for Tuesday (Sept. 19)--(BW HealthWire)--

WHO: Dr. Russell Barkley, author of the best-selling "Taking Charge of ADHD: A Complete Authoritative Guide for Parents," invited presenter to the surgeon general's conference, and lead researcher in the development of the imaging agent Altropane for the diagnosis of ADHD.

WHY: During the past 10 years there has been a 700 percent increase in the use of drugs like ritalin among children. Recent lawsuits allege that drug companies have conspired with the psychiatric community to "create" ADHD in order to boost profits. No objective diagnostic test for ADHD currently exists.

WHAT: Research published last December in The Lancet reports that Altropane shows promise to be the first objective diagnostic test for ADHD. The Altropane test identifies and measures brain biochemical abnormalities specific to patients with ADHD. In addition to establishing a biochemical basis for ADHD, Altropane could eliminate the guesswork currently used to diagnose the disorder.

WHEN: Dr. Barkley is available for interviews today, Tuesday, September 19th, from 2-5PM EST.

MEDIA: In addition to Dr. Barkley, interviews can be scheduled with Marc Lanser, MD, Chief Scientific Officer for Boston Life Sciences, the company developing Altropane. A VNR and b-roll featuring an Altropane brain scan and interviews with patients, parents and doctors are available upon request.